¡Ya estamos en ! Descubre más
APEN

Apollo Endosurgery, Inc.

Excluida de cotización

APEN dejó de cotizar en bolsa el 3 de abril de 2023.

 

Acerca de: Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.

Empleados: 202

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre APEN.

Gráficos de precios implementados con Lightweight Charts™